RxSight, Inc. to Report First Quarter Financial Results on May 9, 2023
RxSight, Inc. (NASDAQ: RXST) announced that it will report its first quarter 2023 financial results on May 9, 2023, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
RxSight, Inc. (NASDAQ: RXST) announced that it will report its first quarter 2023 financial results on May 9, 2023, after market close. Management is set to discuss the results during a conference call beginning at 1:30 PM PT / 4:30 PM ET. This call aims to provide insights into the company’s financial performance and future outlook following their innovative advancements in ophthalmic medical devices, specifically their Light Adjustable Lens system designed for cataract surgery. The technology is unique as it allows for post-surgery adjustments to optimize patients' vision quality. Interested investors can register for the call and access it via a live and archived webcast.
Positive
- Upcoming financial results presentation may provide insights into growth.
- Innovative Light Adjustable Lens system allows for customized vision correction post-surgery, potentially leading to increased sales.
Negative
- None.
Details
News Market Reaction – RXST
The recorded move for RXST in the trading session of this news was +0.29%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALISO VIEJO, Calif., April 25, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the first quarter 2023 after the market close on Tuesday, May 9, 2023. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Participants may register for the call here and listen through a live and archived webcast of the event available for one year at https://investors.rxsight.com/. While not required, it is recommended that participants join ten minutes prior to the event start time to ensure the necessary audio applications are downloaded and installed. Instructions are provided (including a dial-in option).
About RxSight, Inc.
RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery enabling doctors to customize and deliver high-quality of vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com
Investor Relations Contact:
ir@rxsight.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.